Cargando…

New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring

Anticoagulation therapy is mandatory in patients with pulmonary embolism to prevent significant morbidity and mortality. The mainstay of therapy has been vitamin-K antagonist therapy bridged with parenteral anticoagulants. The recent approval of new oral anticoagulants (NOACs: apixaban, dabigatran,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudd, Kelly M., Phillips, Elizabeth (Lisa) M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649748/ https://www.ncbi.nlm.nih.gov/pubmed/23691304 http://dx.doi.org/10.1155/2013/973710

Ejemplares similares

Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
por: Ghazvinian, R., et al.
Publicado: (2018)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2018)

Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?
por: Penner, Leonie S., et al.
Publicado: (2022)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk
por: Cid, Allison, et al.
Publicado: (2022)

Pulmonary embolism in patients with COVID-19 pneumonia on adequate oral anticoagulation
por: Di Tano, Giuseppe, et al.
Publicado: (2021)

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
por: Boon, Gudula J. A. M., et al.
Publicado: (2020)

New Prospective for the Management of Low-Risk Pulmonary Embolism: Prognostic Assessment, Early Discharge, and Single-Drug Therapy with New Oral Anticoagulants
por: Squizzato, Alessandro
Publicado: (2012)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
por: Sajkov, Dimitar, et al.
Publicado: (2015)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
por: Honore, Patrick M., et al.
Publicado: (2020)

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism
por: Boon, Gudula J. A. M., et al.
Publicado: (2020)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
por: Cheung, Ka-Shing, et al.
Publicado: (2017)

Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)

Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings
por: Ghazvinian, Raein, et al.
Publicado: (2020)

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
por: Dubinski, Daniel, et al.
Publicado: (2021)

Association Between the Use of Pre- and Post-thrombolysis Anticoagulation With All-Cause Mortality and Major Bleeding in Patients With Pulmonary Embolism
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Risk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-Analysis
por: Skaistis, Joel, et al.
Publicado: (2015)

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?
por: Lijfering, Willem M., et al.
Publicado: (2018)

Aminaphtone for Light Bleeding in Patients Under Oral Anticoagulation
por: Pereira de Godoy, José Maria, et al.
Publicado: (2010)

Management of bleeding in patients treated with direct oral anticoagulants
por: Levi, Marcel
Publicado: (2016)

Evaluation of bleeding in patients receiving direct oral anticoagulants
por: Hellenbart, Erika L, et al.
Publicado: (2017)

Efficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension
por: Gatto, Maria Chiara, et al.
Publicado: (2023)

Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention
por: Habert, Jeffrey Steven
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
por: Gremmel, Thomas, et al.
Publicado: (2018)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

ANMCO Position Paper: the use of non-vitamin K dependent new oral anticoagulant(s) in pulmonary embolism therapy and prevention
por: Enea, Iolanda, et al.
Publicado: (2017)

Understanding Bleeding Risk after Anticoagulation
Publicado: (2005)

Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
por: Rankin, James, et al.
Publicado: (2016)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
por: Cambron, Julia C., et al.
Publicado: (2020)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
por: FEI, JIANWEN, et al.
Publicado: (2014)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023)

Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
por: Gómez-Outes, Antonio, et al.
Publicado: (2014)

Safety and efficacy of catheter-directed therapy versus anticoagulation alone in a higher-risk acute pulmonary embolism population
por: Putnam, Andrew, et al.
Publicado: (2021)

Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
por: Chang, Hsien-Yen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6oerfjs5kp6klhqabcedpttb1m